1. Home
  2. BHM vs IXHL Comparison

BHM vs IXHL Comparison

Compare BHM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

N/A

Current Price

$9.28

Market Cap

40.1M

Sector

Real Estate

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.20

Market Cap

37.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHM
IXHL
Founded
2022
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
37.0M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
BHM
IXHL
Price
$9.28
$3.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
4.8K
241.9K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$68,734,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.88
N/A
52 Week Low
$8.05
$0.16
52 Week High
$14.50
$6.39

Technical Indicators

Market Signals
Indicator
BHM
IXHL
Relative Strength Index (RSI) 37.20 41.34
Support Level $8.05 $3.07
Resistance Level $9.60 $4.12
Average True Range (ATR) 0.19 0.25
MACD -0.00 -0.04
Stochastic Oscillator 0.00 9.73

Price Performance

Historical Comparison
BHM
IXHL

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: